Fucoidan (Brown Seaweed Polysaccharide)

Fucoidan is worth trying at 6.0–6.5/10 for the right person: someone who wants a cheap, very safe immune and anti-inflammatory adjunct from a whole-food source and who keeps their expectations honest about thin human evidence. The score is justified by a strong safety record, a coherent mechanism, and a centuries-long tradition of safe seaweed consumption, balanced against a research base that is mostly preclinical with only small, underpowered human trials. It sits a notch above heavily marketed metabolic drugs precisely because it is cheap, low-conflict, and well tolerated, even though its demonstrated efficacy is modest. Avoid it if you take blood thinners or have surgery coming up.

✅ Best for: Older adults wanting gentle immune support before vaccination or cold season, mirroring the Negishi 2013 protocol; people managing a chronic inflammatory load who want a low-risk adjunct alongside the basics; cancer patients exploring evidence-based supportive options strictly under oncologist supervision, given the Tsai 2017 disease-control signal; biohackers drawn to the Okinawan-diet longevity association who treat fucoidan as one piece of a broader pattern; and anyone who prefers a whole-food-derived supplement with a clean tolerability profile over a synthetic alternative.

❌ Avoid if: You take anticoagulants such as warfarin or direct oral anticoagulants, antiplatelet drugs, or have a bleeding disorder, because fucoidan's heparin-like activity prolonged aPTT in Irhimeh 2009; you have surgery scheduled within two weeks and have not stopped it; you are pregnant or breastfeeding, where safety data are insufficient; you expect a metabolic or blood-sugar benefit, since one isolated-fucoidan trial worsened insulin resistance; or you are buying an unspecified product that does not disclose its source species and fucoidan content, since potency and anticoagulant activity vary widely by species.